Working… Menu

Clinico-biological Data Collection Study of Metastatic Breast Cancer (EPICUREseinmet)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03958136
Recruitment Status : Recruiting
First Posted : May 21, 2019
Last Update Posted : May 24, 2019
European Regional Development Fund
Eli Lilly and Company
Information provided by (Responsible Party):
Institut Cancerologie de l'Ouest

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 24, 2033
Estimated Study Completion Date : December 30, 2034